GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Genetic Analysis AS (XSAT:GEAN.TO.2) » Definitions » Cash Flow from Discontinued Operations

Genetic Analysis AS (XSAT:GEAN.TO.2) Cash Flow from Discontinued Operations : kr0.00 Mil (TTM As of Dec. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Genetic Analysis AS Cash Flow from Discontinued Operations?

Cash flow from discontinued operations is the cash received by a company that comes from the sale of part of business.

Genetic Analysis AS's cash flow from discontinued operations for the three months ended in Dec. 2023 was kr0.00 Mil. It means Genetic Analysis AS received kr0.00 Mil from the sale of part of business quarterly. Genetic Analysis AS's cash flow from discontinued operations for the trailing twelve months (TTM) ended in Dec. 2023 was kr0.00 Mil.

Genetic Analysis AS Cash Flow from Discontinued Operations Historical Data

The historical data trend for Genetic Analysis AS's Cash Flow from Discontinued Operations can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Genetic Analysis AS Cash Flow from Discontinued Operations Chart

Genetic Analysis AS Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Cash Flow from Discontinued Operations
- - - - -

Genetic Analysis AS Quarterly Data
Dec19 Jun20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Cash Flow from Discontinued Operations Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Genetic Analysis AS Cash Flow from Discontinued Operations Calculation

Cash received by a company that comes from the sale of part of business.

Cash Flow from Discontinued Operations for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was kr0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Genetic Analysis AS Cash Flow from Discontinued Operations Related Terms

Thank you for viewing the detailed overview of Genetic Analysis AS's Cash Flow from Discontinued Operations provided by GuruFocus.com. Please click on the following links to see related term pages.

Genetic Analysis AS (XSAT:GEAN.TO.2) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Genetic Analysis AS (XSAT:GEAN.TO.2) » Definitions » Cash Flow from Discontinued Operations
Comparable Companies
OSTO:IMMNOV XSAT:SPERM OSTO:PROGEN XSAT:CALMA B XSAT:ALPH NGM:ATANA TMO DHR SHSE:603259 IQV IDXX A XSWX:LONN MTD ICLR LH ILMN DGX WAT EXAS
Traded in Other Exchanges
GEAN:Sweden
Address
Kabelgata 8, Oslo, NOR, 0580
Website
https://www.genetic-analysis.com
Genetic Analysis AS is a research-driven diagnostic company dedicated to delivering innovative diagnostic solutions to the growing human microbiota market. It is providing a CE-marked gut microbiota analysis for testing bacterial imbalance in IBS and IBD patients.

Genetic Analysis AS (XSAT:GEAN.TO.2) Headlines

No Headlines